LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in LENZ Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- +9 vs. Q2 2021
- Shares held
- 36.0M
- +3.78M (+11.7%) vs. Q2 2021
- Total value
- $587.4M
- −$394.1M (−40.2%) vs. Q2 2021
- New holders
- 29
- 12 more added
- Sold out
- 20
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 7,431,623 | $121.8M | 20.22% | 00.0% | Unchanged |
| FMR LLC | 6,249,606 | $101.1M | 0.01% | +2,487,627+66.1% | Added |
| Ra Capital Management, L.P. | 2,698,369 | $44.2M | 0.61% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 2,076,710 | $34.0M | 0.72% | −75,028−3.5% | Reduced |
| VR Adviser, LLC | 1,612,617 | $26.4M | 3.39% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,449,904 | $23.8M | 0.26% | +343,597+31.1% | Added |
| Citadel Advisors LLC | 1,270,173 | $20.5M | 0.02% | −18,052−1.4% | Reduced |
| Logos Global Management LP | 1,206,308 | $19.8M | 1.43% | +135,546+12.7% | Added |
| Federated Hermes, Inc. | 1,056,308 | $17.3M | 0.03% | +406,308+62.5% | Added |
| BlackRock Inc. | 949,914 | $15.6M | 0.00% | +846,333+817.1% | Added |
| Janus Henderson Group PLC | 958,079 | $15.2M | 0.01% | −292,926−23.4% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 906,308 | $14.9M | 0.29% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 875,093 | $14.3M | 0.21% | 00.0% | Unchanged |
| Avidity Partners Management LP | 748,995 | $12.3M | 0.31% | +13,495+1.8% | Added |
| Board of Trustees of The Leland Stanford Junior University | 703,071 | $11.5M | 0.86% | −630−0.1% | Reduced |
| Artal Group S.A. | 700,000 | $11.5M | 0.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 696,431 | $11.4M | 0.00% | +666,431+2,221.4% | Added |
| Norges Bank | 554,167 | $9.08M | 0.00% | −145,833−20.8% | Reduced |
| Millennium Management LLC | 541,147 | $8.87M | 0.01% | −48,686−8.3% | Reduced |
| Sphera Funds Management Ltd. | 531,269 | $8.71M | 0.86% | +506,312+2,028.7% | Added |
| UBS Asset Management Americas Inc | 442,704 | $7.26M | 0.00% | +48,917+12.4% | Added |
| Morgan Stanley | 413,765 | $6.78M | 0.00% | +150,263+57.0% | Added |
| Woodline Partners LP | 300,031 | $4.92M | 0.08% | −9,692−3.1% | Reduced |
| Jennison Associates LLC | 296,375 | $4.86M | 0.00% | −3,625−1.2% | Reduced |
| Geode Capital Management, LLC | 257,376 | $4.22M | 0.00% | +257,376 | New |
| Cormorant Asset Management, LP | 203,153 | $3.26M | 0.13% | 00.0% | Unchanged |
| State Street Corp | 196,641 | $3.22M | 0.00% | +196,641 | New |
| Northern Trust Corp | 143,199 | $2.35M | 0.00% | +143,199 | New |
| Goldman Sachs Group Inc | 74,109 | $1.22M | 0.00% | −200,317−73.0% | Reduced |
| HighVista Strategies LLC | 60,905 | $998.0K | 0.66% | +60,905 | New |
| D. E. Shaw & Co., Inc. | 53,472 | $876.0K | 0.00% | +53,472 | New |
| Caas Capital Management LP | 40,000 | $656.0K | 0.05% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 39,797 | $653.0K | 0.00% | +39,797 | New |
| Bank of New York Mellon Corp | 39,394 | $646.0K | 0.00% | +39,394 | New |
| Nuveen Asset Management, LLC | 34,311 | $562.0K | 0.00% | +34,311 | New |
| Bank of America Corp | 30,513 | $500.0K | 0.00% | +30,313+15,156.5% | Added |
| Ghisallo Capital Management LLC | 15,000 | $246.0K | 0.01% | −25,000−62.5% | Reduced |
| Rhumbline Advisers | 11,746 | $193.0K | 0.00% | +11,746 | New |
| Cetera Advisor Networks LLC | 11,400 | $187.0K | 0.00% | +11,400 | New |
| Deutsche Bank AG | 9,347 | $153.0K | 0.00% | +9,347 | New |
| American International Group, Inc. | 8,893 | $146.0K | 0.00% | +8,893 | New |
| California State Teachers Retirement System | 8,780 | $144.0K | 0.00% | +8,780 | New |
| Cubist Systematic Strategies, LLC | 8,677 | $142.0K | 0.00% | +8,677 | New |
| SG Americas Securities, LLC | 7,247 | $119.0K | 0.00% | +7,247 | New |
| MetLife Investment Management | 6,861 | $112.5K | 0.00% | +6,861 | New |
| JPMorgan Chase & Co | 6,224 | $102.0K | 0.00% | +6,224 | New |
| New York State Common Retirement Fund | 5,700 | $93.0K | 0.00% | +5,700 | New |
| Metropolitan Life Insurance Co | 5,191 | $85.1K | 0.00% | +5,191 | New |
| Point72 Asset Management, L.P. | 5,000 | $82.0K | 0.00% | −5,000−50.0% | Reduced |
| STRS Ohio | 3,700 | $60.0K | 0.00% | +3,700 | New |
| Wells Fargo & Company | 2,952 | $48.0K | 0.00% | +2,952 | New |
| UBS Group AG | 2,509 | $41.0K | 0.00% | +2,509 | New |
| Royal Bank of Canada | 1,916 | $32.0K | 0.00% | +1,884+5,887.5% | Added |
| Citigroup Inc | 1,887 | $31.0K | 0.00% | +1,887 | New |
| Legal & General Group Plc | 1,519 | $25.0K | 0.00% | +1,519 | New |
| Advisor Group Holdings, Inc. | 1,320 | $22.0K | 0.00% | +1,320 | New |
| Ameritas Investment Partners, Inc. | 1,246 | $20.0K | 0.00% | +1,246 | New |
| Tower Research Capital LLC (TRC) | 681 | $11.0K | 0.00% | +681 | New |
| Federation des caisses Desjardins du Quebec | 200 | $3.28K | 0.00% | +200 | New |
| American Portfolios Advisors | 20 | $328 | 0.00% | +20 | New |
| SB Management Ltd | 0 | $0 | 0.00% | −993,402−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −52,543−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | 0 | $0 | 0.00% | −51,039−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −36,646−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −19,232−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,225−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,700−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −7,709−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,576−100.0% | Sold out |